News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CLINUVEL announces relocation of its corporate headquarters to the United States.
  • The company plans to reduce its global workforce by 10–20%.
  • CLINUVEL shifts its operational focus exclusively to the U.S. pharmaceutical market.
  • The move aims to improve access to U.S. investors and capital markets.
  • Restructuring is intended to better position CLINUVEL's late-stage pipeline, notably its vitiligo treatment, for U.S. commercialization.

Latest Articles

USA Rare Earth Finalizes Definitive Agreements with U.S. Department of Commerce, Unlocking Access to Up to $1.6 Billion to Advance the Leading Rare Earth Value Chain

USA Rare Earth Finalizes Definitive Agreements with U.S. Department of Commerce, Unlocking Access to Up to $1.6 Billion to Advance the Leading Rare Earth Value Chain

USA Rare Earth has finalized agreements with the U.S. Department of Commerce to access up to $1.6 billion in funding under the CHIPS Act, supplementing $1.5 billion in private capital raised earlier. The combined ~$3.5 billion capital will be used to develop and expand its vertically integrated domestic rare earth mining, processing, metal, and mag…

Citi: Strategy’s Modest Bitcoin Sale Does Not Alter BTC’s Core Outlook

Citi: Strategy’s Modest Bitcoin Sale Does Not Alter BTC’s Core Outlook

Citi analysts view Strategy’s recent disposal of a small Bitcoin holding as unsurprising and not materially changing the cryptocurrency’s fundamental outlook. The bank emphasizes that exchange-traded fund (ETF) flows continue to explain a large share of weekly price variance, while negative recent ETF flows and uncertainty over U.S. market structur…

Treasure Global Reports Preliminary Fiscal Year 2026 Financial Outlook; Revenue Growth Expected to Exceed 100% Year-over-Year

Treasure Global Reports Preliminary Fiscal Year 2026 Financial Outlook; Revenue Growth Expected to Exceed 100% Year-over-Year

Treasure Global Inc. announced a preliminary fiscal year 2026 financial outlook expecting revenue growth exceeding 100% year-over-year due to expansion in its digital ecosystem and merchant adoption across Southeast Asia. The company highlights operational enhancements, fintech infrastructure development including digital wallets and AI capabilitie…

Quantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance Sheet

Quantum Cyber Publishes Inaugural Corporate Investor Presentation Showcasing System-of-Systems Autonomous Defense Platform, Eight Filed Patent Positions, LOIs With General Cherry and SOCOM, and $15 Million Debt-Free Balance Sheet

Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, published its inaugural Corporate Investor Presentation. The comprehensive presentation consolidates the company's milestones including an AI-powered System-of-Systems platform, eight filed patent positions, Letters of Intent (LOIs) with General Cherry and SOCOM, and a stron…

Visteon Executive Activity and Stock Performance Under Scrutiny

Visteon Executive Activity and Stock Performance Under Scrutiny

Senior Vice President Robert R. Vallance recently sold shares in Visteon Corp (NASDAQ:VC) through a pre-arranged trading plan. This activity occurred while the stock trades near its 52-week high, following a period of strong company performance and mixed quarterly results that included both revenue beats and EPS misses.

Wall Street's Top Bull Signals Short-Term Caution Amid Record S&P Levels

Wall Street's Top Bull Signals Short-Term Caution Amid Record S&P Levels

Yardeni Research, which holds the highest year-end S&P 500 target on Wall Street at 8,250, says it is adopting a cautious stance on equities in the near term even as the S&P 500 surpassed 7,600 for the first time. The firm flagged a set of near-term risks - an unresolved Middle East conflict, warnings from major oil executives about low inventories…

Novo Nordisk: Deep Value Buy Ahead of a 2027 Growth Rebound

Novo Nordisk: Deep Value Buy Ahead of a 2027 Growth Rebound

Novo Nordisk is trading at roughly $43 with a market cap near $193B and a P/E of ~10. The market has punished the stock for near-term pricing and competition in GLP-1 drugs, but fundamentals - recurring revenue from diabetes and obesity care, an expanding oral Wegovy adoption, and a healthy dividend - argue for a re-rating if growth normalizes in 2…

TransUnion Expands TruIQ™ Data Enrichment on Snowflake AI Data Cloud to Power Prescreen Credit Marketing Campaigns

TransUnion Expands TruIQ™ Data Enrichment on Snowflake AI Data Cloud to Power Prescreen Credit Marketing Campaigns

TransUnion announced an expansion of its TruIQ Data Enrichment platform integrated with the Snowflake AI Data Cloud to support prescreen credit marketing campaigns, enabling customers to access and activate enriched credit data more quickly and securely within their own Snowflake environments. This new capability reduces campaign activation time fr…

New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology

New Expert Consensus Provides Age-Specific Guidance for Improving Care for Individuals with Genital Psoriasis Published in the American Journal of Clinical Dermatology

Arcutis Biotherapeutics announces publication of a new expert consensus manuscript in the American Journal of Clinical Dermatology offering age-specific guidance for diagnosis and management of genital psoriasis across pediatric, adult, and older populations. The paper promotes routine genital assessment, empathetic communication, and individualize…

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities

RadNet, Inc., a leading US outpatient diagnostic imaging provider, announced its intention to secure a $200 million incremental term loan. This funding aims to support future acquisitions, organic expansion, health system partnerships, and other corporate purposes to accelerate strategic growth across its national imaging network and technology pla…

Diginex Provides Update on Proposed Resulticks Acquisition

Diginex Provides Update on Proposed Resulticks Acquisition

Diginex Limited announced the extension of the long stop date to June 12, 2026 for its proposed acquisition of Resulticks Global Companies Pte. Limited. The acquisition aims to significantly expand Diginex's platform by integrating ESG data with real-time decisioning and customer engagement capabilities. Resulticks is expected to bring approximatel…

AT&T: Deep Value, Growing FCF, and a Clear Path to Re-rating

AT&T: Deep Value, Growing FCF, and a Clear Path to Re-rating

AT&T trades at single-digit earnings multiples with a healthy free cash flow profile, a roughly 4.5% dividend yield, and a $19 billion California fiber commitment that demonstrates capital allocation toward durable growth assets. We present a long trade with disciplined risk controls that targets a meaningful multiple expansion while capturing inco…

WTW receives DFSA licence approval to operate investment business in Dubai International Financial Centre (DIFC)

WTW receives DFSA licence approval to operate investment business in Dubai International Financial Centre (DIFC)

WTW (NASDAQ: WTW), a global advisory and solutions firm, has received approval from the Dubai Financial Services Authority to operate as WTW Investments (DIFC) Limited in Dubai International Financial Centre. This licence enables WTW to offer regulated investment advisory services and fund solutions locally, marking a strategic expansion in the gro…

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions

NewAmsterdam Pharma announced multiple presentations at the National Lipid Association 2026 Scientific Sessions showcasing data on obicetrapib, their novel oral low-dose CETP inhibitor for hypercholesterolemia treatment. The presentations cover efficacy, safety, and potential cardiovascular benefits based on extensive Phase 2 and 3 clinical trials.…

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer

CytomX Therapeutics has expanded its collaboration with Regeneron Pharmaceuticals to advance conditionally activated bispecific immunotherapies utilizing CytomX's PROBODY platform and Regeneron's Veloci-Bi technology. The expanded deal includes a $37 million target selection payment and potential milestones totaling approximately $4 billion as Rege…

Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA

Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA

Spyre Therapeutics has completed enrollment for all sub-studies in its SKYWAY basket trial evaluating SPY072, an anti-TL1A antibody, across rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA). The company reaffirms expected clinical data readouts in Q3 2026 for RA and Q4 2026 for PsA and axSpA, supporting poten…